N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl- d -aspartate receptor activity
| Autor: | Marlene A. Jacobson, P. Jeffrey Conn, Douglas J. Pettibone, Cyrille Sur, Jacinta B. Williams, Danette Pascarella, Marion Wittmann, Philip E. Brandish, Edward M. Scolnick, Pierre Mallorga |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
Agonist
DNA Complementary Time Factors medicine.drug_class Biology Pharmacology Hippocampus Receptors N-Methyl-D-Aspartate Muscarinic agonist Cell Line Inhibitory Concentration 50 chemistry.chemical_compound Cricetinae Muscarinic acetylcholine receptor M5 Muscarinic acetylcholine receptor M4 medicine Animals Humans Clozapine Neurons Multidisciplinary Dose-Response Relationship Drug Receptor Muscarinic M1 Brain Muscarinic acetylcholine receptor M3 Muscarinic acetylcholine receptor M2 Muscarinic acetylcholine receptor M1 Biological Sciences Rats Electrophysiology chemistry Guanosine 5'-O-(3-Thiotriphosphate) Mutagenesis Site-Directed Xanomeline Allosteric Site Protein Binding |
| Zdroj: | Proceedings of the National Academy of Sciences. 100:13674-13679 |
| ISSN: | 1091-6490 0027-8424 |
| Popis: | The molecular and neuronal substrates conferring on clozapine its unique and superior efficacy in the treatment of schizophrenia remain elusive. The interaction of clozapine with many G protein-coupled receptors is well documented but less is known about its biologically active metabolite, N -desmethylclozapine. Recent clinical and preclinical evidences of the antipsychotic activity of the muscarinic agonist xanomeline prompted us to investigate the effects of N -desmethylclozapine on cloned human M1-M5 muscarinic receptors. N -desmethylclozapine preferentially bound to M1 muscarinic receptors with an IC 50 of 55 nM and was a more potent partial agonist (EC 50 , 115 nM and 50% of acetylcholine response) at this receptor than clozapine. Furthermore, pharmacological and site-directed mutagenesis studies suggested that N -desmethylclozapine preferentially activated M1 receptors by interacting with a site that does not fully overlap with the acetylcholine orthosteric site. As hypofunction of N -methyl- d -aspartate (NMDA) receptor-driven neuronal ensembles has been implicated in psychotic disorders, the neuronal activity of N -desmethylclozapine was electrophysiologically investigated in hippocampal rat brain slices. N -desmethylclozapine was shown to dose-dependently potentiate NMDA receptor currents in CA1 pyramidal cells by 53% at 100 nM, an effect largely mediated by activation of muscarinic receptors. Altogether, our observations provide direct evidence that the brain penetrant metabolite N -desmethylclozapine is a potent, allosteric agonist at human M1 receptors and is able to potentiate hippocampal NMDA receptor currents through M1 receptor activation. These observations raise the possibility that N -desmethylclozapine contributes to clozapine's clinical activity in schizophrenics through modulation of both muscarinic and glutamatergic neurotransmission. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|